Addition of interleukin-2 in vitro augments detection of lymphokine-activated killer activity generated in vivo.

Hank JA, Weil-Hillman G, Surfus JE, Sosman JA, Sondel PM
Cancer Immunol Immunother. 1990 31 (1): 53-9

PMID: 2306756 · DOI:10.1007/BF01742496

MeSH Terms (8)

Cells, Cultured Cytotoxicity, Immunologic Dose-Response Relationship, Drug Humans Interleukin-2 In Vitro Techniques Killer Cells, Lymphokine-Activated Recombinant Proteins

Connections (1)

This publication is referenced by other Labnodes entities: